FDA Clearance Tracker · P970053
EC-5000 EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 17, 1998 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 1998
Approved
Time to decision
406 days
Received Nov 6, 1997. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P970053
- Device name
- EC-5000 EXCIMER LASER SYSTEM
- Applicant
- Nidek Co., Ltd.
- Applicant location
- Gamagori
- Received
- Nov 6, 1997
- Decided
- Dec 17, 1998
- Decision
- Approved
- Supplements
- 16 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the Nidek EC-5000 Excimer Laser System. This device is indicated for photorefractive keratectomy (PRK) for the reduction or elimination of mild to moderate myopia in patients with the following three characterisitics: 1) In PRK treatments for the reduction or elimination of myopia in the low, moderate, or high ranges (-0.75 Diopters (D) to -13.00D) spherical equivalent (S.E.) at the spectacle plan, uncomplicated by refractive astigmatism (i.e., <0.75D in any meridian). 2) In patients who have a stable history of pretreatment myopia, that is a change of < 0.50D in sphere or cylinder in the 12 months period preceding treatment for correction of myopia <-7.0D S.E., or a change of <1.00D in sphere or cylinder for correction of myopia >-7.0D S.E. 3) In patients who are over 21 years of age.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LZS. The earliest in FDA's data is P910067, decided Mar 10, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Nidek Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K221320 · Decided Mar 30, 2023 · 328 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.